Semalutide, glucagon joalo ka peptide (GLP-1) receptor agonist, e amohetsoe bakeng sa kalafo ea lefu la tsoekere la mofuta oa 2. Somaglutide e thehiloe ke Novo Nordisk ho 2012 e le mokhoa oa nako e telele oa Liraglutide. Ha ho bapisoa le Liraglutide le meriana e meng ea lefu la tsoekere, e 'ngoe ea melemo ea Somaglutide ke hore e na le nako e telele ea ketso, kahoo hang ka beke ente e lekane. Ka December 2017, US Food and Drug Administration (FDA) e amohetse mofuta oa ente ea somalitide. Teko ea kliniki ea karolo ea II e fetileng e fumane hore Somaglutide e fokolitse boima ba bakuli ba lefu la tsoekere la mofuta oa 2 le batho ba batenya haholo, 'me ho lahleheloa ke boima ba' mele ho ne ho nkoa e le ka lebaka la ho fokotseha ha matla a matla a bakoang ke ho fokotsa takatso ea lijo.